S 4134
116th Congress
Senate
Health
Congressional oversight
Government studies and investigations
Health care costs and insurance
Health information and medical records
Health programs administration and funding
Medicare
Prescription drugs
Increasing Access to Biosimilars Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 1, 2020
Read twice and referred to the Committee on Finance.
Jul 1, 2020
Introduced in Senate
Plain-English summary
Increasing Access to Biosimilars Act of 2020
This bill requires the Centers for Medicare & Medicaid Services to establish a demonstration project to evaluate the benefits of providing additional payments to providers of biosimilars under Medicare. Specifically, under the demonstration project, participating providers receive an additional payment based on the difference between the costs to the provider of furnishing the biosimilar and the cost if the provider had furnished the underlying reference biological product instead.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1